Topical Application of Calcium Channel Blockers to Reduce the Progression of Experimentally Induced Myringosclerosis and Tympanosclerosis

Selcuk, Adin; Akdogan, Ozgur; Ozcan, Ibrahim; Giray, Seren; Dere, Huseyin; Ozogul, Candan

doi:10.1097/mlg.0b013e31815ed115

Topical Application of Calcium Channel Blockers to Reduce the Progression of Experimentally Induced Myringosclerosis and Tympanosclerosis

Copy For Citation

Selcuk A., Akdogan O., Ozcan I., Giray S. G. , Dere H., Ozogul C.

LARYNGOSCOPE, vol.118, no.4, pp.697-705, 2008 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 118 Issue: 4
Publication Date: 2008
Doi Number: 10.1097/mlg.0b013e31815ed115
Title of Journal : LARYNGOSCOPE
Page Numbers: pp.697-705

Abstract

Objectives: This study aimed to evaluate the ability of topically applied calcium channel blockers (diltiazem) to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.